Clinical Trials
84 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
Yantai LNC Biotechnology Singapore PTE. LTD.
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
SL VAXiGEN
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma
Fudan University
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
MDPK67b in Patients With Prostate Cancer
Med Discovery SA
IMMUNOs-SBRT
Centre Georges Francois Leclerc
CAT_PB
Lebanese University
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
Chongqing Precision Biotech Co., Ltd
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Chongqing Precision Biotech Co., Ltd
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms
Changhai Hospital
Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
Qilu Pharmaceutical Co., Ltd.
225AcPSMAI&T
Erasmus Medical Center
A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects
Jiangsu HengRui Medicine Co., Ltd.
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
Luye Pharma Group Ltd.
A Study of BPI-452080 in Subjects With Solid Tumors
Betta Pharmaceuticals Co., Ltd.
WEE1
Impact Therapeutics, Inc.
Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
Shanghai Humantech Biotechnology Co. Ltd
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
MICROBIOME
Imperial College London
A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC
Jiangsu HengRui Medicine Co., Ltd.
Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
Lindis Biotech GmbH
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Sichuan University
In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours
University Hospital Bispebjerg and Frederiksberg
Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Radboud University Medical Center
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
University of Lausanne Hospitals
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors
Sheba Medical Center
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
Peptron, Inc.
Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion
Jiangsu HengRui Medicine Co., Ltd.
Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
Shanghai Junshi Bioscience Co., Ltd.
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
CytoMed Therapeutics Pte Ltd
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
SHARP
Fundacao Champalimaud
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
PSA
OncBioMune Pharmaceuticals
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
Biocad
A Study of BCD-135 in Patients With Advanced Solid Tumors
Biocad
A Study Evaluating MM-310 in Patients With Solid Tumors
Merrimack Pharmaceuticals